Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II
Clinical trial NCT07131722 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07131722
- Sponsor
- PRG Science & Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-01
- Primary completion
- 2028-07-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.